Dr Brendon Neuen is an academic nephrology registrar and NHMRC Postgraduate Scholar at The George Institute for Global Health. He graduated in medicine at James Cook University with 1st Class Honours and an Academic Medal and holds a Masters in Global Health from Oxford University, where he was fully funded by a Clarendon Scholarship and received the prize for the top ranked dissertation.
His research focuses on the efficacy and safety of new glucose lowering medications in people with diabetes and chronic kidney disease, having led several analyses of the landmark CANVAS and CREDENCE trials. He is involved in ongoing international multi-centre randomized trials and has published over 60 peer-reviewed articles and conference proceedings in general medical journals including the BMJ and Annals of Internal Medicine, and specialty journals including Lancet Diabetes and Endocrinology, Circulation, and the Journal of the American Society of Nephrology. His work has directly informed major international clinical practice guidelines which define best practice for the care of people with type 2 diabetes.
In addition, he is a Senior Editorial Fellow at the Journal of the American Society of Nephrology and serves on boards or committees of the Australasian Kidney Trials Network and the International Society of Nephrology.